Hyperactive kids three times as likely to be removed from thei...( d as yet there is no public or professi...)

Hyperactive kids three times as likely to be removed from their families

d as yet there is no public or professional consensus on the use of drugs to stabilise hyperactive children.

The disorder challenges "not only our professional tolerance but also the way paediatric services for all community based childhood disorders are currently structured," writes Dr Mary Mather, a consultant community paediatrician.

Hyperactive children are not a priority, she continues. "Yet their outcomes are poor. Many will fail or be excluded from school. Others will suffer the social consequences of their impulsive behaviours in secure units or prison."

'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ Specialty Journals
20-Feb-2005

Page: 1 2
Related medicine news :

1. Success of liver transplantation may be most influenced by three risk factors
2. New system for the analysis of facial movement in three dimensions
3. Study examines three-day antibiotic regimens for treating bladder infection in women
4. Falling in love in three minutes or less
5. Alcohol drinkers three times as likely to die from injury
6. HHS awards $10.4 million to fight AIDS on three continents
7. Testing drugs ability to reverse stroke after standard three-hour window has closed
8. Researchers: Diet a significant factor in reducing risk of three common cancers
9. Multi-center trial compares three medications in patients with heart failure
10. One in eight N.C. schoolchildren display three or more heart risks
11. Antiepileptic drug developed at Hebrew University to undergo phase three clinical trials

Post Your Comments:

(Date:11/26/2009)...tions announces a highly effective and unconventio...g to make an economic recovery. , ... the type of challenge that could send ailing holi...David Benton, business growth expert and author of... The Rfactor Intensive . “Fear is one of ...

(Date:11/25/2009)...wswire/--WhenmostpeopleheartheacronymTMJ,theythink...thehelptheyneed.TMJstandsfortheTemporal-Mandibular...tswithyourskull(temporalbone). ,, Themostcommon...wing,clickingorpoppingofthejaw.Butmanyothersymptom...fatigue,sleepdisturbances,irritability,alossinfocu...

(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...

(Date:11/25/2009)...lleMedicalInc.,aleadingmanufacturerofbreastMRIcoil...ewleadingedgeclinicalapplicationsonitsAegis(TM)med...lSocietyofNorthAmerica(RSNA)annualmeetinginChicago...sleveragetheuniquehighqualityimagesgeneratedbySent...leimagingmodalitiesformulti-parametricassessment. ...

(Date:11/25/2009)...-USNewswire/--AnarticlebyJanetWoodcock,M.D.,direct...led"ADifficultBalance-PainManagement,DrugSafety,an...ndJournalofMedicine. ,, (Logo: http://www.newsc...article,WoodcockdiscussesFDAeffortstostrikeabalanc...managingtherisksposedbyvariousanalgesics.Asexample...

Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2 Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3

[0] Pharmacist Injects Cure for Ailing Businesses [1] TMJ and Chiropractic Care: An Overall Wellness Approach [0] Onyx Pharmaceuticals Announces December 2009 Investor Events [1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology [1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine

(Date:11/25/2009)..., EASTBRUNSWICK,N.J.,Nov.25/PRNewswire/--SwissrayI...alRadiography( ddR )systems,announcedtodaythatitso...thalongtermviewtowardsgrowingSwissray,smedicalimag...ctualproperty,aswellascontractsandinventory.After2...othenextleveloftechnologicaladvancementswithstable...

(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.comanno...atalogue: ,, PainManagement-GlobalTrends ,...agement---Global-Trends.html ,, Widespreadavai...inics,andtheadventofnewdrugshaveacceleratedthepace...sandreimbursementstructurecontinuetoshapedemandfor...

(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoC...atafromtheCompany,sPROTECT-1(theProspectiveRandomi...aficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-s...hafavorablesafetyandtolerabilityprofile.Thestudyde...ofdiseaseseverityasdefinedasa70-pointdecreaseinthe...

Breaking Medicine Technology:Swissray International Announces New Ownership 2 Reportlinker Adds Pain Management - Global Trends 2 Reportlinker Adds Pain Management - Global Trends 3 Reportlinker Adds Pain Management - Global Trends 4 Reportlinker Adds Pain Management - Global Trends 5 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5 Questionnaire May Help Spot Early Dementia 48426 1 Questionnaire May Help Spot Early Dementia 48426 2 Questionnaire May Help Spot Early Dementia 48426 3 MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 1 MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 2 MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 3 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 1 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 2 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 3 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 4

[0] Swissray International Announces New Ownership [0] Reportlinker Adds Pain Management - Global Trends [0] ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference

Other News:

...Nov. 9, 2002 A preliminary study reports that enh...toms of Crohn's disease in 80 percent of patients ... inflammatory gastrointestinal disorder. ......The... The Lancet by investigators at Washington Univers...

...anagement teams, faced with an approaching hurrica...ures for real-time decision making on issues rangi...acuating assisted-living facilities by using a com..... The research team says the system also can assi...

...-- Although individuals vary widely, on average, p...information -- including understanding what they s...his deficit in processing speed is already present...nce does not narrow with age. The research is publ...

The successful transfusion of a cell-free blood product on a 14-year-old Jehovah's Witness may offer a solution for patients opposed to blood transfusions due to religious or personal beliefs......."T

health news:New treatment strategy for Crohn's disease shows early promise 2 health news:New treatment strategy for Crohn's disease shows early promise 3 health news:Map data goes live with voice, gesture-based computer system 2 health news:Map data goes live with voice, gesture-based computer system 3 health news:Pre-term infants slower than full-terms at processing information 2

New treatment strategy for Crohn's disease shows early promise Map data goes live with voice, gesture-based computer system Pre-term infants slower than full-terms at processing information Physicians offer new solution for blood transfusions

Were you ever tell you to "wrap up warm or you'll catch a cold?" If so, scientists at Cardiff University's Common Cold Centre have proved this right. ...For the first time, new research, publishe

...cs has mainly addressed ethical issues at the indi...octor relationship. The ethical issues arising in ...ly vexing and often involve higher stakes. This co...itiates its exploration.......Dates:...Thursday, N...

A growing body of research on older consumers reveals that as we grow older we become more emotional. This emotion often causes susceptibility to misleading advertising. But in a forthcoming article i

... Pumps implanted into the chest to maintain circu...ickest patients in end-stage heart failure who are...ng to the results of a clinical trial led by Duke ...pumps, known as left ventricular assistant devices...

health news:Chilling can cause colds 2 health news:Population-level bioethics: Mapping a new agenda 2 health news:Population-level bioethics: Mapping a new agenda 3 health news:Implantable pumps extend lives of patients too sick for transplant 2 health news:Implantable pumps extend lives of patients too sick for transplant 3

Chilling can cause colds Population-level bioethics: Mapping a new agenda Older consumers prefer emotional appeals Implantable pumps extend lives of patients too sick for transplant

Hyperactive kids three times as likely to be removed from thei...( d as yet there is no public or professi...),Health